• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚甲基丙烯酸甲酯骨水泥中高剂量和低剂量万古霉素:疗效与力学性能

High and Low Dosage of Vancomycin in Polymethylmethacrylate Cements: Efficacy and Mechanical Properties.

作者信息

Kwong Jeffrey W, Abramowicz Michael, Kühn Klaus Dieter, Foelsch Christian, Hansen Erik N

机构信息

Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, CA 94143, USA.

KABEG, LKH Villach, 9500 Villach, Austria.

出版信息

Antibiotics (Basel). 2024 Aug 28;13(9):818. doi: 10.3390/antibiotics13090818.

DOI:10.3390/antibiotics13090818
PMID:39334991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11428212/
Abstract

INTRODUCTION

Prosthetic joint infections (PJIs) are difficult to treat and represent a significant burden to the healthcare system. Two-stage revision surgery with placement of an antibiotic-loaded cement spacer is currently the gold standard for treatment in the United States for late-onset infections. We evaluate the efficacy of varying doses of vancomycin added to antibiotic-containing acrylic cement spacers and discuss the biomechanical and antimicrobial properties of using high versus low doses of vancomycin in cement spacers in the hip and knee.

MATERIALS AND METHODS

Commercially available Copal cement containing either gentamicin and clindamycin (G + C) or gentamicin and vancomycin (G + V) was prepared with the manual addition of low (2 g) and high (6 g) doses of vancomycin. In vitro mechanical testing was then carried out according to ISO 5833 and DIN 53435, as well as inhibition zone assays against common PJI pathogens. Additionally, inhibition zone assays were conducted on two commercially available prefabricated spacers containing gentamicin: Copal Exchange G and Cemex Spacer-K.

RESULTS

In biomechanical testing, Copal G + V with the addition of 6 g of vancomycin failed to meet the ISO standard. Copal G + C and Copal G + V with low and high dosages of vancomycin were all effective against the tested pathogens and displayed constant efficacy for a duration of 42 days. High doses of vancomycin showed significantly lower mechanical stability. Moreover, Copal Exchange G showed significantly larger inhibition zones across 42 days.

DISCUSSION

While higher concentrations of vancomycin appear to improve the antimicrobial efficacy of cement, they also reduce its mechanical stability. Despite its smoother surface, the Copal Exchange G spacer exhibits large inhibition zones after 1 day and maintains consistently large inhibition zones over 6 weeks. Thus, it may be preferred for use in two-stage revision surgery.

CONCLUSION

Copal Exchange G is more effective than Cemex Spacer K against and . The manual addition of vancomycin to cement containing double antibiotics is very effective. The influence on ISO compression is low, the ISO bending modulus is increased, and ISO bending, DIN bending, and DIN impact, are reduced.

摘要

引言

人工关节感染(PJI)难以治疗,给医疗系统带来了沉重负担。在美国,采用含抗生素的骨水泥间隔器的两阶段翻修手术目前是治疗迟发性感染的金标准。我们评估了添加不同剂量万古霉素的含抗生素丙烯酸骨水泥间隔器的疗效,并讨论了在髋部和膝部骨水泥间隔器中使用高剂量与低剂量万古霉素的生物力学和抗菌特性。

材料与方法

通过手动添加低剂量(2克)和高剂量(6克)万古霉素,制备了含有庆大霉素和克林霉素(G + C)或庆大霉素和万古霉素(G + V)的市售科帕尔骨水泥。然后根据ISO 5833和DIN 53435进行体外力学测试,以及针对常见PJI病原体的抑菌圈试验。此外,对两种市售含庆大霉素的预制间隔器进行了抑菌圈试验:科帕尔交换G和西麦斯间隔器 - K。

结果

在生物力学测试中,添加6克万古霉素的科帕尔G + V未达到ISO标准。添加低剂量和高剂量万古霉素的科帕尔G + C和科帕尔G + V对受试病原体均有效,并在42天内显示出持续疗效。高剂量万古霉素显示出明显较低的机械稳定性。此外,科帕尔交换G在42天内显示出明显更大的抑菌圈。

讨论

虽然较高浓度的万古霉素似乎可提高骨水泥的抗菌疗效,但也会降低其机械稳定性。尽管科帕尔交换G间隔器表面更光滑,但在1天后显示出较大的抑菌圈,并在6周内保持一致的大抑菌圈。因此,它可能更适合用于两阶段翻修手术。

结论

科帕尔交换G在对抗……方面比西麦斯间隔器K更有效。向含双重抗生素的骨水泥中手动添加万古霉素非常有效。对ISO压缩的影响较小,ISO弯曲模量增加,而ISO弯曲、DIN弯曲和DIN冲击则降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/1e32fedd9b96/antibiotics-13-00818-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/064684512a71/antibiotics-13-00818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/d846ac3ab973/antibiotics-13-00818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/2c3931263fb0/antibiotics-13-00818-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/db3cadeba580/antibiotics-13-00818-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/f50d6b031d9e/antibiotics-13-00818-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/ac42dec1e2cb/antibiotics-13-00818-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/95cca2c24984/antibiotics-13-00818-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/354a4b4cdf81/antibiotics-13-00818-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/92c449cf084c/antibiotics-13-00818-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/fe27c09cb97d/antibiotics-13-00818-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/1e32fedd9b96/antibiotics-13-00818-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/064684512a71/antibiotics-13-00818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/d846ac3ab973/antibiotics-13-00818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/2c3931263fb0/antibiotics-13-00818-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/db3cadeba580/antibiotics-13-00818-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/f50d6b031d9e/antibiotics-13-00818-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/ac42dec1e2cb/antibiotics-13-00818-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/95cca2c24984/antibiotics-13-00818-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/354a4b4cdf81/antibiotics-13-00818-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/92c449cf084c/antibiotics-13-00818-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/fe27c09cb97d/antibiotics-13-00818-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e9/11428212/1e32fedd9b96/antibiotics-13-00818-g011.jpg

相似文献

1
High and Low Dosage of Vancomycin in Polymethylmethacrylate Cements: Efficacy and Mechanical Properties.聚甲基丙烯酸甲酯骨水泥中高剂量和低剂量万古霉素:疗效与力学性能
Antibiotics (Basel). 2024 Aug 28;13(9):818. doi: 10.3390/antibiotics13090818.
2
Mechanical strength of antibiotic-loaded PMMA spacers in two-stage revision surgery.载抗生素 PMMA spacer 在二期翻修术中的机械强度。
BMC Musculoskelet Disord. 2022 Oct 29;23(1):945. doi: 10.1186/s12891-022-05895-5.
3
Impact of Manual Addition of Vancomycin to Polymethylmethacrylate (PMMA) Cements.手动向聚甲基丙烯酸甲酯(PMMA)骨水泥中添加万古霉素的影响。
Antibiotics (Basel). 2024 Aug 1;13(8):721. doi: 10.3390/antibiotics13080721.
4
Comparison of elution characteristics and mechanical properties of acrylic bone cements with and without superficial vancomycin coating (SVC) in the late phase of polymerization.比较聚合后期有和没有表面万古霉素涂层(SVC)的丙烯酸骨水泥的洗脱特性和力学性能。
Orthop Traumatol Surg Res. 2021 Jun;107(4):102908. doi: 10.1016/j.otsr.2021.102908. Epub 2021 Mar 28.
5
Daptomycin-Impregnated PMMA Cement against Vancomycin-Resistant Germs: Dosage, Handling, Elution, Mechanical Stability, and Effectiveness.含达托霉素的聚甲基丙烯酸甲酯骨水泥对抗万古霉素耐药菌:剂量、操作、洗脱、机械稳定性及有效性
Antibiotics (Basel). 2023 Oct 26;12(11):1567. doi: 10.3390/antibiotics12111567.
6
Comparison of Elution Characteristics and Compressive Strength of Biantibiotic-Loaded PMMA Bone Cement for Spacers: Copal® Spacem with Gentamicin and Vancomycin versus Palacos® R+G with Vancomycin.双抗生素载药 PMMA 骨水泥 spacer 的洗脱特性和抗压强度比较:含庆大霉素和万古霉素的 Copal® Spacem 与含万古霉素的 Palacos® R+G。
Biomed Res Int. 2018 Oct 16;2018:4323518. doi: 10.1155/2018/4323518. eCollection 2018.
7
Alteration of Masquelet's induced membrane characteristics by different kinds of antibiotic enriched bone cement in a critical size defect model in the rat's femur.在大鼠股骨临界尺寸缺损模型中,不同种类含抗生素骨水泥对Masquelet诱导膜特性的影响。
Injury. 2016 Feb;47(2):325-34. doi: 10.1016/j.injury.2015.10.079. Epub 2015 Nov 10.
8
Loading with vancomycin does not decrease gentamicin elution in gentamicin premixed bone cement.万古霉素负载不会降低庆大霉素预混骨水泥中庆大霉素的洗脱量。
J Mater Sci Mater Med. 2017 Jul;28(7):104. doi: 10.1007/s10856-017-5915-6. Epub 2017 May 22.
9
Vancomycin-Gentamicin Prefabricated Spacers in 2-Stage Revision Arthroplasty for Chronic Hip and Knee Periprosthetic Joint Infection: Insights Into Reimplantation Microbiology and Outcomes.万古霉素-庆大霉素预制型间隔物在慢性髋关节和膝关节假体周围关节感染二期翻修中的应用:再植入微生物学和结果的见解。
J Arthroplasty. 2020 Jan;35(1):247-254. doi: 10.1016/j.arth.2019.07.043. Epub 2019 Aug 19.
10
Do High Doses of Multiple Antibiotics Loaded into Bone Cement Spacers Improve the Success Rate in Staphylococcal Periprosthetic Joint Infection When Rifampicin Cannot Be Employed?当无法使用利福平时,加载到骨水泥间隔物中的高剂量多种抗生素能否提高葡萄球菌人工关节感染的成功率?
Antibiotics (Basel). 2024 Jun 10;13(6):538. doi: 10.3390/antibiotics13060538.

引用本文的文献

1
Biomechanical impact of enoxaparin sodium-chitosan-PMMA bone cement in hip arthroplasty: a preliminary finite element analysis.依诺肝素钠-壳聚糖-聚甲基丙烯酸甲酯骨水泥在髋关节置换术中的生物力学影响:初步有限元分析
Front Surg. 2025 Jun 24;12:1615456. doi: 10.3389/fsurg.2025.1615456. eCollection 2025.
2
Evaluation and testing of polymethylmetacrylic (PMMA) bone cements with admixed Amphotericin B.含两性霉素B的聚甲基丙烯酸甲酯(PMMA)骨水泥的评估与测试。
J Orthop Surg Res. 2025 Feb 8;20(1):151. doi: 10.1186/s13018-025-05565-x.
3
Intra-articular injection of vancomycin after arthrotomy closure following gentamicin-impregnated bone cementation in primary total knee arthroplasty provides a high intra-articular concentration while avoiding systemic toxicity: a prospective study.

本文引用的文献

1
Success Rate After 2-Stage Spacer-Free Total Hip Arthroplasty Exchange and Risk Factors for Reinfection: A Prospective Cohort Study of 187 Patients.两阶段无间隔 spacer 全髋关节翻修术后的成功率和再感染的风险因素:187 例患者的前瞻性队列研究。
J Arthroplasty. 2024 Oct;39(10):2600-2606. doi: 10.1016/j.arth.2024.05.010. Epub 2024 May 15.
2
Effect of Antibiotic Spacer Dosing on Treatment Success in Two-Stage Exchange for Periprosthetic Joint Infection.抗生素 spacer 给药对二期翻修治疗假体周围关节感染的疗效影响。
J Am Acad Orthop Surg Glob Res Rev. 2024 Feb 22;8(2). doi: 10.5435/JAAOSGlobal-D-23-00103. eCollection 2024 Feb 1.
3
在初次全膝关节置换术中,在庆大霉素骨水泥固定后的关节切开闭合后关节内注射万古霉素,可提供高关节内浓度,同时避免全身毒性:一项前瞻性研究。
J Orthop Surg Res. 2024 Dec 19;19(1):856. doi: 10.1186/s13018-024-05357-9.
Daptomycin-Impregnated PMMA Cement against Vancomycin-Resistant Germs: Dosage, Handling, Elution, Mechanical Stability, and Effectiveness.
含达托霉素的聚甲基丙烯酸甲酯骨水泥对抗万古霉素耐药菌:剂量、操作、洗脱、机械稳定性及有效性
Antibiotics (Basel). 2023 Oct 26;12(11):1567. doi: 10.3390/antibiotics12111567.
4
Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients.人工关节周围感染中利福平耐药的发生率:一项针对238例患者的单中心队列研究
Antibiotics (Basel). 2023 Sep 30;12(10):1499. doi: 10.3390/antibiotics12101499.
5
Enhanced antibiotic release from bone cement spacers utilizing dual antibiotic loading with elevated vancomycin concentrations in two-stage revision for periprosthetic joint infection.利用双抗生素加载并提高万古霉素浓度,从骨水泥间隔器中增强抗生素释放,用于二期翻修治疗假体周围关节感染。
Int Orthop. 2023 Nov;47(11):2655-2661. doi: 10.1007/s00264-023-05922-7. Epub 2023 Aug 11.
6
Survivorship and Clinical Outcomes of Primary Total Knee Arthroplasty Performed in Patients 35 Years of Age and Younger.35 岁及以下患者行初次全膝关节置换术的生存状况和临床结果。
J Arthroplasty. 2023 Nov;38(11):2316-2323.e1. doi: 10.1016/j.arth.2023.05.068. Epub 2023 Jun 5.
7
Voriconazole Admixed with PMMA-Impact on Mechanical Properties and Efficacy.伏立康唑与聚甲基丙烯酸甲酯混合——对机械性能和疗效的影响
Antibiotics (Basel). 2023 May 4;12(5):848. doi: 10.3390/antibiotics12050848.
8
Acute kidney injury in the context of staged revision arthroplasty and the use of antibiotic-laden cement spacers: a systematic review.分期翻修关节成形术和使用载抗生素骨水泥间隔器相关的急性肾损伤:系统评价。
J Orthop Surg Res. 2023 May 9;18(1):340. doi: 10.1186/s13018-023-03809-2.
9
The Practice Patterns of American Association of Hip and Knee Surgeons for the Management of Chronic Periprosthetic Joint Infection After Total Knee Arthroplasty.美国髋关节和膝关节外科医师协会治疗全膝关节置换术后慢性假体周围关节感染的实践模式。
J Arthroplasty. 2023 Nov;38(11):2441-2446. doi: 10.1016/j.arth.2023.04.059. Epub 2023 May 2.
10
Local Antibiotic Delivery Options in Prosthetic Joint Infection.人工关节感染中的局部抗生素递送方法
Antibiotics (Basel). 2023 Apr 14;12(4):752. doi: 10.3390/antibiotics12040752.